Grant: Master's Award: Canada Graduate Scholarships
McGill University
$27,000.00
The Role of the METex14del Mutation in Promoting Lung Cancer Progression
EF 2024-25
Résumé
Lung cancer is a significant health issue globally, particularly in Canada, where it is the leading cause of cancer-related deaths. Many individuals diagnosed with lung cancer face challenges as the disease often progresses to an advanced stage, making it harder to treat. However, we have identified a specific genetic alteration known as METex14del, which could hold promise for targeted therapy for a subset of early-stage lung cancer patients. This alteration is significant because we show that it plays a role in how lung cancer develops and spreads. By focusing on this change, I propose to gain an understanding of its role in early-stage lung cancer. More specifically, I want to understand how METex14del promotes lung cancer progression due to differences in gene expression patterns. Ultimately, this research could lead to better outcomes and improved treatment options for individuals affected by lung cancer, starting from the early stages of the disease.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
529806
Name
Brien Vanessa
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
The Role of the METex14del Mutation in Promoting Lung Cancer Progression
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Bioinformatics; Cancer Genetics; Genomics; Lung Cancer; Met Proto-Oncogene; Mutation; Oncology; Spatial Transcriptomics; Targeted Therapy; Tyrosine Kinase Receptor
Abstract
Lung cancer is a significant health issue globally, particularly in Canada, where it is the leading cause of cancer-related deaths. Many individuals diagnosed with lung cancer face challenges as the disease often progresses to an advanced stage, making it harder to treat. However, we have identified a specific genetic alteration known as METex14del, which could hold promise for targeted therapy for a subset of early-stage lung cancer patients. This alteration is significant because we show that it plays a role in how lung cancer develops and spreads. By focusing on this change, I propose to gain an understanding of its role in early-stage lung cancer. More specifically, I want to understand how METex14del promotes lung cancer progression due to differences in gene expression patterns. Ultimately, this research could lead to better outcomes and improved treatment options for individuals affected by lung cancer, starting from the early stages of the disease.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Brien, Vanessa
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~